Terence K. Lee

13.7k total citations · 5 hit papers
170 papers, 10.8k citations indexed

About

Terence K. Lee is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Terence K. Lee has authored 170 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 60 papers in Oncology and 43 papers in Cancer Research. Recurrent topics in Terence K. Lee's work include Cancer Cells and Metastasis (28 papers), Cancer, Hypoxia, and Metabolism (17 papers) and Ubiquitin and proteasome pathways (16 papers). Terence K. Lee is often cited by papers focused on Cancer Cells and Metastasis (28 papers), Cancer, Hypoxia, and Metabolism (17 papers) and Ubiquitin and proteasome pathways (16 papers). Terence K. Lee collaborates with scholars based in Hong Kong, China and United States. Terence K. Lee's co-authors include Stephanie Ma, Irene Oi‐Lin Ng, Xin‐Yuan Guan, Kwok Wah Chan, Kwan Ho Tang, Kwan Man, Eunice Y. Lau, Bo‐Jian Zheng, Sheung Tat Fan and Antonia Castilho and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Terence K. Lee

160 papers receiving 10.7k citations

Hit Papers

Identification and Characterization of Tumorigenic Liver ... 2007 2026 2013 2019 2007 2007 2011 2021 2025 250 500 750

Peers

Terence K. Lee
Stephanie Ma Hong Kong
Anuradha Budhu United States
Ju‐Seog Lee United States
Valentina M. Factor United States
Stephanie Ma Hong Kong
Terence K. Lee
Citations per year, relative to Terence K. Lee Terence K. Lee (= 1×) peers Stephanie Ma

Countries citing papers authored by Terence K. Lee

Since Specialization
Citations

This map shows the geographic impact of Terence K. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terence K. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terence K. Lee more than expected).

Fields of papers citing papers by Terence K. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terence K. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terence K. Lee. The network helps show where Terence K. Lee may publish in the future.

Co-authorship network of co-authors of Terence K. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Terence K. Lee. A scholar is included among the top collaborators of Terence K. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terence K. Lee. Terence K. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Martina Mang Leng, et al.. (2025). Deciphering adenosine signaling in hepatocellular carcinoma: Pathways, prognostic models, and therapeutic implications. Clinical and Molecular Hepatology. 31(3). 706–729. 2 indexed citations
2.
Leung, Carmen Oi Ning, Yang Yang, Karl Kam Hei So, et al.. (2023). Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma. Nature Communications. 14(1). 6699–6699. 35 indexed citations
3.
Leung, Hoi-Wing, Carmen Oi Ning Leung, Eunice Y. Lau, et al.. (2021). EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma. Cancer Research. 81(12). 3229–3240. 102 indexed citations
4.
Lee, Terence K., et al.. (2021). Hampering Stromal Cells in the Tumor Microenvironment as a Therapeutic Strategy to Destem Cancer Stem Cells. Cancers. 13(13). 3191–3191. 10 indexed citations
5.
Huang, Yuhua, Chris Zhiyi Zhang, Joe Yeong, et al.. (2020). Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma. Journal of Hepatology. 74(4). 838–849. 69 indexed citations
6.
Mao, Xiaowen, Sze Keong Tey, Cherlie Lot Sum Yeung, et al.. (2020). Nidogen 1‐Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1. Advanced Science. 7(21). 2002157–2002157. 72 indexed citations
8.
Leung, Carmen Oi Ning, Man Tong, Noélia Che, et al.. (2019). Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain–Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma. Hepatology. 72(1). 155–168. 73 indexed citations
9.
Wong, Tin Lok, Kai‐Yu Ng, Kel Vin Tan, et al.. (2019). CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis–Driven Hepatocarcinogenesis via ERK‐Dependent PKM2 Nuclear Relocalization and Activation. Hepatology. 71(4). 1279–1296. 91 indexed citations
10.
Gong, Chun, Ellen P.S. Man, Ho Tsoi, et al.. (2018). BQ323636.1, a Novel Splice Variant to NCOR 2, as a Predictor for Tamoxifen-Resistant Breast Cancer. Clinical Cancer Research. 24(15). 3681–3691. 19 indexed citations
11.
Cheng, Bowie Y., Eunice Y. Lau, Hoi-Wing Leung, et al.. (2018). IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma. Cancer Research. 78(9). 2332–2342. 83 indexed citations
12.
Chan, Lok-Hei, Stella Chai, Man Tong, et al.. (2017). TP53INP1 Downregulation Activates a p73-Dependent DUSP10/ERK Signaling Pathway to Promote Metastasis of Hepatocellular Carcinoma. Cancer Research. 77(17). 4602–4612. 42 indexed citations
13.
Xu, Ai‐Min, Cathy C. Zhang, Peter Olson, et al.. (2017). Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1–Stat3. Molecular Cancer Therapeutics. 16(8). 1531–1543. 60 indexed citations
14.
Wong, Tin Lok, Man Tong, Terence K. Lee, et al.. (2017). FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB–BMP Signaling Cross-talk. Cancer Research. 77(21). 5886–5899. 48 indexed citations
15.
Ma, Stephanie, Yuen Piu Chan, Pak Shing Kwan, et al.. (2011). MicroRNA-616 Induces Androgen-Independent Growth of Prostate Cancer Cells by Suppressing Expression of Tissue Factor Pathway Inhibitor TFPI-2. Cancer Research. 71(2). 583–592. 5 indexed citations
16.
Ma, Stephanie, et al.. (2010). MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2. The HKU Scholars Hub (University of Hong Kong). 70 indexed citations
17.
Ma, Stephanie, Kwok Wah Chan, Terence K. Lee, et al.. (2008). Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations. Molecular Cancer Research. 6(7). 1146–1153. 383 indexed citations
18.
19.
Man, Kwan, TP Ng, Chung Mau Lo, et al.. (2007). Ischemia-Reperfusion of Small Liver Remnant Promotes Liver Tumor Growth and Metastases—Activation of Cell Invasion and Migration Pathways. Liver Transplantation. 13(12). 1669–1677. 111 indexed citations
20.
Zhou, Rita, Ming‐Tat Ling, Terence K. Lee, et al.. (2005). FTY720, a fungus metabolite, inhibits invasion ability of androgen independent prostate cancer cells through inactivation of RhoA-GTPase. Cancer Research. 65. 158–158. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026